Company
Medium Biosciences
Custom affinity reagents, designed for your target and application
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- research teams and diagnostic developers
Record updated 17 September 2026
About
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
Products
- Other
- Custom affinity reagents